2009
DOI: 10.1016/j.bmcl.2009.04.128
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis and biological evaluation of novel γ-carboline analogues of Dimebon as potent 5-HT6 receptor antagonists

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
23
0

Year Published

2009
2009
2024
2024

Publication Types

Select...
8

Relationship

2
6

Authors

Journals

citations
Cited by 45 publications
(23 citation statements)
references
References 18 publications
0
23
0
Order By: Relevance
“…The resulting activity was favorably compared with Dimebon I (Fig. 1) obtained following the method reported in our recent work [45]. Under normal conditions, HEK293 cells continuously produce recombinant human serotonin 5-HT 6 receptors.…”
Section: Resultsmentioning
confidence: 98%
See 1 more Smart Citation
“…The resulting activity was favorably compared with Dimebon I (Fig. 1) obtained following the method reported in our recent work [45]. Under normal conditions, HEK293 cells continuously produce recombinant human serotonin 5-HT 6 receptors.…”
Section: Resultsmentioning
confidence: 98%
“…1). The evaluated compounds of the general formula III are closely related in structure to compounds II, which have also been prepared recently and tested in vitro using a similar biological assay in our laboratory [45]. The overall aim of the present study is to investigate the spectrum of biological activity and selectivity of the title compounds against a panel of serotonin receptors as well as against histamine H 1 receptor.…”
Section: Introductionmentioning
confidence: 99%
“…It is being currently evaluated in advanced clinical trials as a promising small molecule drugcandidate for the treatment of Alzheimer's (Phase III) and Huntington's (Phase II) diseases [7]. Various pharmacological properties of dimebolin have been studied extensively [8][9][10][11][12]. Dimebolin possesses a remarkably broad spectrum of molecular target activity as well as a very complex mechanism of action, which allows one to consider it as an excellent example of a drug within the specific group of 'magic shotgun' drugs [13].…”
Section: Introductionmentioning
confidence: 99%
“…Furthermore, a series of putative HDAC inhibitors bearing -and -carboline scaffolds has recently been patented for use as anti-cancer therapeutics by Grigg,10 with the most promising candidates being AC148 (5) and AC190 (6). An important requirement for biological activity within these systems appears to be the presence of a benzamide moiety, which is thought to bind to zinc ion present in the active site of the HDAC enzyme.…”
Section: Introductionmentioning
confidence: 99%